Bicara Therapeutics at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Bicara Therapeutics at ESMO 2026 in Madrid: Booth 8012.
| Organization | ESMO 2026 Attendance |
|---|---|
Clinical-stage biotech developing ficerafusp alfa, an EGFR/TGF-beta bifunctional antibody, for head and neck cancer. | Booth Exhibiting at Booth 8012 |
Instantly find 20 buyers from Bicara Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction